Feb 19th - Controlled Substances Regulation Conference
Next Wednesday will be interesting. Also, the letter sent from Congress to Obama today was not a coincidence. Just in time for the Controlled Substance Conference... Here is the agenda and players. Any positive shift from this conference will be a game changer.
This one-day conference focuses on significant developments in FDA and DEA’s regulation of controlled substances. The program brings together government, industry and public health experts to provide updates on the latest regulations, litigation, and enforcement actions affecting controlled substances’ stakeholders. Experts will review key developments in 2013 and discuss what to expect in 2014. A roundtable discussion will address recent scheduling decisions and their practical and policy impacts. Panelists will dialogue with attendees on current issues, including the regulation of marijuana and suspicious order monitoring.
Who Will Attend
Attorneys, regulatory staff and compliance personnel who work with manufacturers of controlled substances
Regulatory affairs professionals and scientists who work in the area of controlled substances
Pharmacists, medical professionals, public health and consumer advocates, and other individuals working with controlled substances
Academics and other research organizations and members of the press who study and/or report on issues related to controlled substances
The article I read said the letter was sent by XTRM. They have a subsidiary that plans on growing. Any thoughts on XTRM? It's only a .03 stock. could be a cheap one to get in on without risking much. Thoughts?
Win, Read the pump from XTRM again. I'm referring to 'Congress of the United States of America'. Read the article and letter in the link below and don't buy XTRM ... You will get served. Any company pushing PR with no substance is a Red Flag.
Can't wait, only 3 trading days away (Monday is Presidents day stocks closed I think).
PLACE YOUR BETS. I own 13 cannabis companies. TRTC PHOT and MDBX are my 3 favorite spec. plays and then there is GWPH for much more stable company with Sativex and numerous clinical trials and new products in the pipeline.